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1. Specific lipoproteins binding a-tocopherol but not its known metabolites have been
isolated and identified from cytosol of rat intestinal mucosa and from serum. 2. A time-
study of the appearance of the orally administered a-[3H]tocopherol with these lipo-
proteins indicates that very-low-density lipoprotein of serum acts as a carrier of the
vitamin. 3. The involvement of the mucosal lipoprotein in the absorption of the vitamin
from the intestine has been inferred from observations on the amounts of a-tocopherol in
serum of orotic acid-fed rats where release of lipoproteins from the liver to serum is
completely inhibited. A considerable decrease in the association of a-tocopherol with
serum very-low-density lipoprotein under this condition is interpreted to mean that serum
lipoproteins are limiting factors for the transport of the vitamin across the intestine and
that this is possibly effected by exchange of a-tocopherol between serum very-low-density
lipoprotein and mucosal lipoprotein.
The occurrence of an a-tocopherol-binding lipo-
protein in rat liver cytosol, its isolation and purifi-
cation have been reported in a previous communi-
cation (Rajaram et al., 1973). Since little is known
about the mechanism of absorption and mode of
transport of this vitamin, the present studies were
designed to find out whether similar lipoproteins exist
in the cytosol of intestinal mucosa and in serum and,
if so, their possible involvement in the processes of
absorption and transport of the orally fed vitamin.
Materials and Methods
Chemicals
DL-a-[5-Me-3H]Tocopherol (4.6mCi/mg) was ob-
tained from The Radiochemical Centre, Amersham,
Bucks., U.K. Acrylamide, NN'-methylenebisacryl-
amide and NNN'N'-tetramethylethylenediamine were
purchased from Koch-Light Laboratories Ltd.,
Colnbrook, Bucks., U.K. Sephadex G-200 was
obtained from Pharmacia Fine Chemicals, Uppsala,
Sweden. PPO (2,5-diphenyloxazole), dimethyl-
POPOP [1,4-bis(4-methyl-5-phenyloxazol-2-yl)benz-
ene] and orotic acid monohydrate were purchased
from Sigma Chemical Co., St. Louis, Mo., U.S.A.
All other chemicals used were either AnalaR grade
from BDH Chemicals Ltd., Poole, Dorset, U.K., or
Proanalyst quality from E. Merck A.G., Darmstadt,
Germany.
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Animals and treatment with orotic acid
Male albino rats of the Wistar strain, housed in
individual cages, were fed normal laboratory stock
diet and used when they attained a weight of about
200g. The normal diet contained vitamin-free casein
(18 %), glucose (68 Y.), cellulose (5%), peanut oil (5 %.)
and salt mixture (USP XIV; 4%) The following
vitamins were added to this diet (mg/kg): thiamine
hydrochloride, 2; riboflavin, 4; pyridoxine, 4; cho-
line, 1000; inositol, 1000; p-aminobenzoic acid, 300;
nicotinamide, 100; folic acid, 2.5; vitamin B12, 0.05;
biotin, 0.1; ergocalciferol, 0.042; vitamin K, 10;
a-tocopherol, 50; vitamin A, 1.72; calcium panto-
thenate, 10 (Roels et al., 1964). Orotic acid, when fed,
was mixed into this diet at a concentration of 1%
and animals were maintained on this diet for 1 week.
Methods
Oral administration of a-[3H]tocopherol. DL-a-
[5-Me-3H]Tocopherol (100,uCi) was mixed with
1.2mg of unlabelled DL-a-tocopherol in 95% (v/v)
ethanolic solution. The mixture, after evaporation of
the solvent, was dissolved in 0.5ml of olive oil and
administered orally by stomach tube under light
ether anaesthesia to rats weighing 200g that had
been starved overnight.
Preparation of liver and small-intestinal mucosal
cytosol. Rats under light ether anaesthesia had their
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livers perfused via the hepatic portal vein with
chilled 0.9% NaCl. After perfusion, which took
about 5min, the liver was quickly excised, weighed
and chilled in 0.25M-sucrose containing lOmM-Tris-
HCI buffer, pH7.4, and lmM-EDTA. A 50% liver
homogenate was prepared in the same medium by
using a Potter-Elvehjem-type glass homogenizer
with a Teflon pestle and giving two strokes at a low
speed of 1000-2000rev./min. The homogenate was
centrifuged at 1050OOg for 60min in a Beckman
L265B ultracentrifuge to give clear cytosol which was
withdrawn with a syringe without disturbing the top
fatty layer.
The lumen of the entire small intestine was washed
by flushing several times with 0.25M-sucrose contain-
ing lOmM-Tris-HCl buffer, pH7.4, and 1mM-EDTA
to remove the food particles, and the washings were
checked for counts until free of radioactivity. The
intestine was cut into short lengths, split longitudin-
ally to expose the mucosa and scraped. The mucosal
scrapings were homogenized in 9vol. of a solution
containing 0.25M-sucrose, 1OmM-Tris-HCI (pH7.4),
1mM-EDTA and 0.1 % BaSO4 as described by Huibs-
cher et al. (1965). After an initial centrifugation at
100OOg for lOmin to sediment cell debris, mucus and
mitochondria, the supernatant was spun at 105000g
for 60min to obtain clear cytosol. This was concen-
trated by reverse dialysis against Polywax (poly-
ethylene glycol) 6000 (Koppikar et al., 1971).
Serum was obtained from the blood drawn through
the posterior vena cava.
Sephadex chromatography. A column (1.8cmx
50cm) uniformly packed with Sephadex G-200 gel
and equilibrated with 0.05M-sodium phosphate buffer
(pH7.4) was employed for the isolation and initial
purification of a-tocopherol-binding protein. A
sample of cytosol or serum containing 70-100mg of
protein was loaded on the gel and elution carried out
in the cold (4°C) at a flow rate of 20ml/h with the
phosphate buffer mentioned above, and fractions
(2.5ml) were collected (Koppikar et al., 1971).
Extinction of the various fractions was measured in
a Shimadzu QV 50 spectrophotometer at 280nm in
a 1cm light-path cell. Suitable dilutions of the samples
were made wherever necessary to measure E within
the working range of the instrument.
Thin-layer chromatography. The fractions compris-
ing peak 1 from the Sephadex column were extracted
three times with acetone-light petroleum (b.p. 40-
60°C) (1:2, v/v) (7.5ml of acetone+15ml of light
petroleum each time) and the extracts were eva-
porated to dryness in the dark under a stream of N2.
The residue was dissolved in 0.5ml of ethanol con-
taining 300,ug of carrier a-tocopherol. a-Tocopherol
was separated from interfering lipids by t.l.c. on
silica-gel G with benzene-hexane (19:1, v/v) as de-
veloping solvent. The completed chromatogram was
viewed under u.v. light to mark the a-tocopherol
spots which were quickly scraped and eluted with
2x 1.5ml of absolute ethanol. The u.v.-absorption
spectra of the eluates were recorded in a Perkin-
Elmer-Hitachi double beam spectrophotometer.
Additionally, the eluates were also tested by the
EEmmerie-Engel(1938)reaction.Thechromatographic
plate was exposed to 12 vapour to identify other
spots, if any.
Polyacrylamide-gel electrophoresis. Polyacryl-
amide-gel electrophoresis was carried out in a
3.5 % running gel. The spacer gel of 2.5% polyacryl-
amide, as modified by Koppikar et al. (1971), was
used. All other details of the electrophoretic system
wereessentiallyas described byNarayan etal. (1966a).
Prestaining of the lipoprotein was carried out with
Sudan Black B in ethylene glycol as described by
McDonald & Ribiro (1959). Amido Black was used
as a protein stain.
Uptake in vitro of a-[3H]tocopherol by serum from
mucosal cells of orotic acid-fed rats. a-[5-Me-3H]-
Tocopherol (l00,uCi) was fed orally to orotic acid-
fed rats and 4h later the mucosal scrapings were
collected. A portion (1 g) of the mucosal cell sus-
pension in 2ml of0.25M-sucrose, buffered with 10mM-
Tris-HCl, pH7.4, and lmM-EDTA and containing a
total radioactivity of about 389750c.p.m., was incu-
bated with 1 ml of unlabelled serum either from
normal rat or from orotic acid-fed rat with or without
1 ml of lipoprotein fraction I isolated by Sephadex
chromatography of normal serum. The incubations
were carried out in test tubes at 37°C for 30min in
a Dubonoff metabolic shaker water bath, and then
were chilled immediately and centrifuged quickly
to sediment the mucosal cells. The radioactivity
incorporated into the supernatant was determined.
Analytical methods. Protein determinations were
carried out by the method of Lowry et al. (1951) with
crystalline bovine albumin as standard. Lipids were
extracted by chloroform-methanol (2:1, v/v) and
portions were used for lipid analysis by the method of
Bragdon (1951).
Radioactivity determinations. Portions ofthevarious
samples were spotted on strips (7cmx 1.8cm) of
Whatman 3MM filter papers, dried and placed in
counting vials containing 0.3% PPO and 0.01%
dimethyl-POPOP in lOml -of toluene as scintillator
(Roodyn et al., 1965). Radioactivity was counted in
a Beckman LS-100 liquid-scintillation spectrometer
with 59% instrument efficiency. A comparison of the
effect of filter-paper strips on counting efficiency was
made by measuring the radioactivity of 0.01 ml of
ethanolic DL-a-[5-Me-3H]tocopherol ofknown radio-
activity in the presence and absence of Whatman
3MM filter-paper strips. In the presence of paper
strips the counting efficiency was 12%. All values
reported are actual c.p.m. measured without any
correction being applied. For determining the radio-
activity in the polyacrylamide gel, the gels were sliced
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withathinrazor to isolate the individual bands and the
segments placed in loosely capped vials containing
0.5ml of 30% H202 and incubated at 60°C for 5h
as described by Young & Fulhorst (1965). Portions
of this solution were spotted on Whatman 3MM
strips and counted as described above.
Portions of ethanolic extracts from the silica-gel
t.l.c. plates were also counted for 3H radioactivity.
Results
Association of a-tocopherol with proteins of mucosal
and liver cytosol and serum
A possible binding of orally fed a-(3H]tocopherol
with proteins of mucosal cytosol and serum was
investigated to determine its significance in the
absorption and transport of the vitamin. Rats fed
with 100,cCi of a-[5-Me-3H]tocopherol were killed
after 4h. This time-interval was chosen because
it is known that lipids are maximally absorbed at 3-4h
after oral administration (Fatterpaker, 1952). Sepha-
dex G-200 gel filtration of mucosal cytosol (Fig. la)
gave three distinct protein fractions of which the
first protein peak, eluting between fractions 15 and
20, contained about 87% of the total cytosol
a-[3H]tocopherol. This particular fraction also
showed the presence of lipids when analysed by the
method ofBragdon (1951), indicating that the binding
protein is probably lipoprotein in nature. Vitamin E
was not associated with any other protein fractions of
the cytosol.
The serum proteins were separated into five frac-
tions (Fig. lb). Vitamin E was maximally (82%)
associated with the first protein fraction which had a
specific radioactivity (i.e. c.p.m. in a portion of
protein solution that gives E280 = 1 in a 1cm-light-
path cell) of 5080 c.p.m./E. This fraction, on the basis
of lipid composition, has been shown to contain a
mixture of chylomicrons, VLD lipoprotein* and LD
lipoprotein (S. V. Koppikar, P. Fatterpaker & A.
Sreenivasan, unpublished work). No measurable
radioactivity was found in other fractions.
A simultaneous study of the liver cytosol proteins
(Fig. 1 c) was done for comparison. As has been shown
previously (Rajaram et al., 1973), vitaminE is carried
by a lipoprotein fraction of liver cytosol that comes
immediately after the void volume. The lipoprotein
fractions of liver and mucosal cytosol that carry
vitamin E, as well as that of serum, resemble each
other in their elution pattern.
It was also ascertained that the radioactivity associ-
ated with the lipoprotein fractions of mucosa, serum
and liver was not due to the metabolic products of
a-tocopherol. For this, the first protein fractions
obtained after Sephadex chromatography of these
samples were extracted with acetone-light petroleum
(b.p. 40-60'C) (1: 2, v/v) and the concentrated extract
was subjected to t.l.c. with benzene-hexane (19:1,
v/v) as developing solvent. The completed chromato-
gram in each case revealed a major spot with RF value
0.71 corresponding to that of standard a-tocopherol;
this spot also gave a u.v.-absorption spectrum charac-
teristic of a-tocopherol (Fig. 2), besides showing a
positive Emmerie-Engel (1938) reaction. In addition,
the chromatogram also showed a minor spot with
RF value 0.11, which corresponds to ac-tocopheryl-
quinone. The distribution of radioactivity among
these spots is represented in Table 1. About 75-80%
of the radioactivity in the various fractions could be
* Abbreviations: VLD lipoprotein, very low-density
lipoprotein; LD lipoprotein, low-density lipoprotein.
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Fig. 1. Gelfiltration ofintestinal mucosal cytosol (a), serum (b) and liver cytosol (c)
A Sephadex G-200 column was equilibrated with 0.05M-sodium phosphate buffer (pH7.4). Portions (2ml) of the respective
samples were loaded on the columns and 2.5ml fractions collected. Other details are given in the text. - , E280;
----, radioactivity.
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Fig. 2. U.v.-absorption spectra of a-[3H]tocopherol bound
to lipoproteinfractions
U.v. spectra, showing absorption maxima at 292nm of
a-tocopherol separated by t.l.c. from cytosol of mucosa
(b), serum (c) and liver cytosol (d) respectively. For details
see the Materials and Methods section. The spectrum for
standard a-tocopherol (a) is included for comparison.
Table 1. Percentage recovery of ca-[3H]tocopherol from
lipoprotein fractions
The first lipoprotein fractions obtained after Sephadex
chromatography of cytosol of mucosa and liver and of
serum samples were each extracted with acetone-light
petroleum (b.p. 40-60'C) (1:2, v/v) and a-tocopherol was
separated from the concentrated extract by t.l.c. as
described in the text. R, values of a-tocopherol and a-
tocopherylquinone were 0.71 and 0.11 respectively.
Values in parentheses represent the total radioactivity
(c.p.m.) in the sample used for extraction. Results are
typical of three independent experiments.
a-Tocopherol a-Tocopherylquinone
Sample
Mucosa
(54260)
Serum
(13415)
Liver
(24590)
(c.p.m.) (%recovery) (c.p.m.) (%recovery)
41695 75 780 2.0
10730
19180
80 340 3.0
78 425 2.5
Table 2. Association of a-[H3]tocopherol with serum, liver
and mucosal lipoproteins
a-[5-Me-3HJTocopherol (100Ci/200g body wt.) was
administered orally to rats, and its association with the first
lipoprotein fraction obtained by Sephadex chromato-
graphy of mucosal cytosol, serum and liver cytosol was
studied at various time-intervals. Other details are given
in the text. Values are expressed as specific radioactivities
(i.e. c.p.m. present in a portion of a protein solution that
gives E280 = 1 in a 1cm light-path cell). Results are means
of five independent determinations ±S.E.M.
a-[3H]Tocopherol (c.p.m./E)
Time
(h)
3
4
6
8
18
Mucosal cytosol
4160± 321
19030± 1365
9275± 715
1240+ 95
105± 12
Serum
1700+ 151
5080± 540
1600+ 125
845+ 60
212+ 20
Liver cytosol
8160+620
3388±280
1970+ 165
479± 30
recovered as a-tocopherol and only 2-3% as a-
tocopherylquinone.
In the second experiment (Table 2), the association
of a-[3H]tocopherol with serum, liver and mucosal
cytosol lipoproteins was studied at various time-
intervals after oral administration of the vitamin.
Orally administered vitamin appears in the mucosal
cytosol and blood serum only at 3h after adminis-
tration and not at earlier time-intervals studied,
whereas at 3h the liver cytosol contained no measur-
able radioactivity. The association of a-tocopherol
with these lipoprotein fractions increased with time,
reaching a maximum at 4h after administration and
declining thereafter. The serum showed no further
increase in radioactivity up to 18h.
Further purification of vitamin E-binding lipo-
protein fraction of mucosal and liver cytosol and
serum has been achieved by polyacrylamide-gel
electrophoresis. The first protein peak obtained after
Sephadex chromatography of these samples was
concentrated by reverse dialysis against Polywax 6000
and used for electrophoresis. The proteins of the
mucosal cytosol fraction resolved into five bands of
which the first protein band was a lipoprotein (Plate
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EXPLANATION OF PLATE I
Polvacrylamide-gel electrophoretograni ofmucosal cytosol (a), serum (b) and liver cy)tosol (c) protein fractions
The first protein peak obtained after Sephadex chromatography of these samples was concentrated by reverse dialysis against
Polywax and used for gel electrophoresis. Protein (350,pg) was loaded on the column. For lipoprotein separation a prestained
sample of 1mg equiv. of protein was used. Other details are given in the text. (i) Lipoprotein; (ii) protein.
0. V. RAJARAM, P. FATITERPAKER AND A. SREENIVASAN
.I
(Facing p. 512)
The Biochemical Journal, Vol. 140, No. 3
(a) (b) (c)
EXPLANATION OF PLATE 2
Electrophoretic mobilities ofthe lipoprotein carrying a%-[3H]tocopherol
(a) Mucosal cytosol; (b) serum; (c) liver cytosol. For details see the text.
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Table 3. Relative radioactivity ofthe different lipoprotein/protein bands separable bypolyacrylamide-gel electrophoresis
Details ofelectrophoresis are given in the text and in the legend to Plate 1. The individual bands were sliced, treated with 30°/
H202 and radioactivity determinations were made as described in the text. Values in the bands are expressed as percentage
of the total radioactive (c.p.m.) of all protein fractions (minus blanks) in a given gel. Remaining bands contain negligible
radioactivity. Results are typical of four independent experiments. Maximum radioactivity was observed in the same
fraction in each experiment.
Yo recovery of cx_[3HJtocopherol
Mucosal cytosol
Proteins Lipoproteins Proteins
4.2 8.0 7.2
81.5 79.8 9.4
6.7 - 77.3
3.2 _
6.1
Serum
Lipoproteins Proteins
5.6 6.0
4.5 82.9
84.0 5.5
4.6 3.0
Liver cytosol
Lipoproteins
8.3
84.5
la), which stained with Sudan Black B. Themaximum
recovery of radioactivity from this lipoprotein band
(Table 3) indicated the specific association of vitamin
E with this lipoprotein. The proteins of the serum
fraction resolved into nine well-defined bands of
which three were lipoproteins (Plate lb). Vitamin E
was associated with the lipoprotein band 2. Narayan
et al. (1966b) have measured the electrophoretic
mobilities of the lipoproteins of various density
classes. By using this system it has been shown in our
laboratory (S. V. Koppikar, P. Fatterpaker & A.
Sreenivasan, unpublished work) that fraction I from
Sephadex chromatography ofserum could be resolved
into chylomicrons, VLD lipoprotein and LD lipo-
protein. The association of a-tocopherol with the
lipoprotein band 2 strongly indicates that VLD lipo-
protein is a carrier of orally fed vitamin. The protein
and lipoprotein bands separable from the liver
cytosol fraction are represented for comparison in
Plate 1(c). The presence of a specific a-tocopherol-
binding lipoprotein in this fraction has already been
discussed in our previous communication (Rajaram
et al., 1973). Plate 2 compares the electrophoretic
mobilities of lipoproteins from mucosal cytosol,
serum and liver cytosol carrying a-tocopherol.
The radioactivity in the protein and lipoprotein
bands obtained after electrophoresing the mucosal
and liver cytosol and serum fractions has been repre-
sented in Table 3. In the small-intestinal mucosal
supernatant, protein band I (Table 3) and the corre-
sponding lipoprotein band 1 contained about 80%
of the total radioactivity as against negligible values
in the remaining bands. Protein bands 2 and 3 (Table
3) of serum together account for about 77% of the
total radioactivity. These two bands had very similar
electrophoretic mobility, hence they could not be
individually sliced. They correspond to the lipoprotein
band 2 from which 84% of the radioactivity could
be recovered. For the liver cytosol fraction, protein
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band 1 contained the highest radioactivity and this
corresponds to the lipoprotein band from which 84%
radioactivity could be recovered.
Effect of orotic acid feeding on the absorption and
binding of a-tocopherol with serum lipoproteins
To understand the part played by the lipoprotein
of intestinal mucosa in the transfer of the vitamin
across the intestine, absorption of cx-[3H]tocopherol
was studied in orotic acid-fed rats. It is known that
addition of as little as 1% orotic acid in the diet
completely inhibits the production of lipoproteins
by the liver (Windmueller & Levy, 1967). With this as
a basis, Windmueller & Levy (1968) have tested the
capacity of the intestine to synthesize lipoproteins.
Their results indicate that intestinal lipoprotein
synthesis is not affected by orotic acid feeding. Hence,
we have utilized this treatment as a means of ascer-
taining whether a-tocopherol is transported directly
into serum in association with mucosal lipoprotein
or not. Orotic acid feeding resulted in a 75-80%
Table 4. Effect of orotic acidfeeding on the association of
at-[3H]tocopherol with lipoprotein fractions of serum and
mucosal cytosol
Orotic acid (1%) in the diet was fed to rats for 7 days.
Lipoproteins from serum and intestinal mucosal cytosol
were isolated by Sephadex G-200 gel chromatography as
described in the text. Results are averages of four experi-
ments ±S.E.M.
Group
Orotic acid-fed
Control
a-[3H]Tocopherol (c.p.m./E)
Mucosal Serum
lipoprotein lipoprotein
18120+1150 1215±110
19030± 1365 5080±540
Band
no.
Origin
1
2
3
4
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decrease in the radioactivity of serum lipoprotein
fraction as compared with controls (Table 4). In the
case of mucosal lipoprotein, however, there was no
change in radioactivity. A very low specific radio-
activity of a-[3H]tocopherol in the serum lipoprotein
of orotic acid-fed rats with no change in the radio-
activity of the mucosal lipoprotein probably indi-
cates that a-tocopherol is not carried in toto into serum
bound with mucosal lipoprotein and that the con-
centration of serum VLD lipoprotein may be impor-
tant for optimum transfer of the vitamin across the
intestine.
Uptake of ac-tocopherol by serum from the mucosal
cells in vitro was examined to gain further informa-
tion. Table 5 shows the uptake of a-[3H]tocopherol
by serum from the small-intestinal mucosal cells of
orotic acid-fed rats. Serum isolated from orotic
acid-treated rats takes up 11 % of the label and this
is enhanced to 38% on the addition of VLD lipo-
protein-containing fraction of normal serum to the
incubation medium. Control serum takes up to 33%
of the label which is three times the value for serum
from orotic acid-fed rats. The results thus indicate
that there is enhancement in the uptake of a-toco-
pherol by serum from orotic acid-fed rats upon
addition of VLD lipoprotein fraction of normal
serum.
Table 5. Uptake in vitro ofa-[3H]tocopherolby serumfrom
small intestinal mucosal cells of orotic acid-fed rats
Orotic acid-fed rats weighing about 200g received an oral
dose of lOO1 Ci of a-[5-Me-3H]tocopherol and were killed
4h later. Mucosal cells (1 g) suspended in 2ml of the
homogenizing medium and containing a total radio-
activity of 389750c.p.m. were incubated with 1 ml of serum
for 30min at 370C. The first lipoprotein fraction (VLD
lipoprotein) isolated by Sephadex chromatography of
normal serum (Fig. lb) was concentrated by reverse
dialysis over polyethylene glycol 6000, and 1 ml of concen-
trate containing 20-25mg of protein was added to the
incubation system. Other details are described in the
text. Results are averages of four experiments each with a
different batch of mucosal cells ±S.E.M. P values for signi-
ficance of increase from A to B and A to C are less than
0.01.
Uptake in serum
System
A. Mucosal cells+serum
from orotic acid-fed rats
B. Mucosal cells+serum
from normal rats
C. Mucosal cells+serum
from orotic acid-fed
rats+lipoprotein
fraction of normal serun
(total c.p.m.) (%)
45500±1960 11.7
128360±9471 33.0
147800+ 12400 38.0
Discussion
Despite the numerous studies on the absorption of
a-tocopherol in animals (Simon et al., 1956a; Krish-
namoorthy & Bieri, 1963; Pearson & Barnes, 1968;
Kelleher et al., 1969) and a few in man (Klatskin &
Molander, 1952; Rosenkrantz et al., 1953; Kelleher
& Losowsky, 1970), the mechanism of absorption is
still obscure. Unlike vitamin A, as reported by
Ganguly (1969), vitamin E is not re-esterified during
absorption. This is inferred from several studies
(Simon et al., 1956a,b; Wiss et al., 1962) that have
shown an increase in the amount of free a-tocopherol
in plasma even after oral dosing with a-tocopherol
acetate or a-tocopheryl phosphate. Blomstrand &
Forsgren (1968) have suggested that the route of
absorption is lymphatic and that most ofthe absorbed
vitamin is probably located in the chylomicrons
(Johnson & Pover, 1962). It is known that orally
administered a-tocopherol is absorbed to the extent
of about 20-25% only, the remainder being excreted
in faeces (Simon et al., 1956a).
In our preliminary experiments on the intracellular
distribution of the vitamin, we observed that the
soluble portion of the small-intestinal mucosa con-
tained appreciable radioactivity 4h after oral ad-
ministration of a-[3H]tocopherol. About 40% of
the total radioactivity in the mucosa was associated
with cytosol and the remainder with the particulate
material. The results of the present experiments
indicate that the absorbed a-tocopherol is partly
associated with a lipoprotein fraction of the intestinal
mucosal cytosol separable by Sephadex gel filtration
and polyacrylamide-disc electrophoresis. This is
accompanied by a simultaneous appearance of the
vitamin in the VLD lipoprotein of serum and a lipo-
protein fraction of liver cytosol. The association of
the vitamin with these lipoproteins reaches a maxi-
mum at 4h after administration and declines there-
after. Unlike vitamin A, there is no further increase in
the vitamin content of serum implying that the trans-
ported vitamin is not released back from the liver
into the serum. This suggests that VLD lipoprotein
ofserum may be the carrier of orally fed vitamin.
A variety of metabolic products, chiefly a-toco-
pherylquinone, dimers and trimers, are known to be
formed after administration of the vitamin (Csallany
et al., 1962; Csallany & Draper, 1963; Draper et al.,
1967). Csallany et al. (1970) have successfully sepa-
rated these products by t.l.c. with benzene-hexane
(19:1, v/v) as developing solvent. In the present
investigation, the same solvent system has been
employed for the purification of a-tocopherol.
The results indicate that over 75% of radioactivity
associated with the lipoprotein fraction is due to
a-tocopherol alone. The recovery of radioactivity
as a-tocopherylquinone was negligible and it is
possible that this product could have been formed
1974
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during the isolation procedures. Dimers or trimers,
detectable by this procedure, were absent in the
protein-bound fractions. The results thus rule out the
possibility of any of these metabolic products being
associated with the lipoprotein fraction.
The lipoproteins of the mucosal and liver cytosol
are identical with VLD lipoprotein of serum in their
elution pattern from the Sephadex column (Fig. 1)
and mobility on polyacrylamide gel (Plate 2). The
electrophoretic mobility of these lipoproteins in
a sufficiently large-pore gel of 3.5% polyacrylamide
was rather slow and at higher concentrations (5%
and 7.5% polyacrylamide) these bands could not
penetrate the running gel. The Sephadex gel-filtration
pattern and the electrophoretic behaviour of these
lipoproteins of mucosal and liver cytosol that carry
a-tocopherol strongly indicate that the molecular
size of the binding protein is very high. Of the several
protein bands obtained, vitamin E is associated with
a lipoprotein band in all the cases as seen by the re-
covery of 80% radioactivity in these bands. The
results incidentally give a direct prooffor the presence
of VLD lipoprotein-like lipoprotein in the mucosal
cells of small intestine, though its presence had been
implicated by other workers (Windmueller & Levy,
1968; Kessler et al., 1970). The observed association
of a-tocopherol with the soluble lipoproteins of the
intestinal mucosa is of significance from the point
of view of its possible involvement in the transfer of
a-tocopherol across the intestinal wall. The results
of orotic acid feeding experiments suggests that a-
tocopherol is not secreted directly into serum in
association with mucosal lipoproteins. These studies
also suggested that the concentration of serum VLD
lipoprotein is a limiting factor for optimum transfer
of the vitamin across the intestine, and that this is
possibly effected by an exchange of ac-tocopherol
between mucosal cytosol lipoprotein and serum VLD
lipoprotein, analogous to the exchange of phospho-
lipids among the various plasma lipoproteins (Minari
& Zilversmit, 1963). No increase in the radioactivity
of the mucosal lipoprotein was observed (Table 4) as
would be expected for a feedback mechanism. It is
probable that such an increase may occur in the
mucosal subcellular fractions which may reflect an
increase, perhaps, in the free a-tocopherol. This
possibility needs further investigation. The present
observations are in accordance with the suggestions
of Ganguly et al. (1959) and Glover & Green (1957)
regarding occurrence of specific lipoproteins in the
intestinal mucosa, which help in the transport of
fat-soluble substances like carotenoids, vitamin A,
sterols etc. across the intestine. A probable involve-
ment of a-tocopherol-carrying lipoprotein of liver
cell-sap in the intracellular transport and distribution
of the vitamin has been reported in our previous
communication (Rajaram et al., 1973).
Thus the present observations point to the exis-
tence of specific lipoproteins in rat tissues, i.e. intes-
tinal mucosa, blood and liver cells. The mucosal
lipoprotein that carries the vitamin probably aids in
the absorption of a-tocopherol. The serum VLD
lipoprotein, which represents the transport form is
involved in the carriage of the vitamin to the various
tissues in addition to its important role in the transfer
of the absorbed vitamin across the intestine. Lastly,
the transported vitamin is distributed among the
intracellular organelles, in association with a lipo-
protein of the cytosol probably specific to various
organs.
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